Conmed (MEX:CNMD) Short-Term Debt: MXN3,092 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CNMD Conmed Corp MEX:CNMD
80 GF Score
Price MXN720.00
GF Value MXN989.85
! 3 Warning Signs
View Full Analysis

What is Conmed Short-Term Debt?

Conmed MEX:CNMD 80 Short-Term Debt is MXN3,092 Mil as of Jun. 2026. GuruFocus rates MEX:CNMD with a GF Score™ of 80/100 and a GF Value™ of MXN989.85. The stock has 3 warning signs investors should review.

Conmed's Short-Term Debt for the quarter that ended in Jun. 2026 was MXN3,092 Mil.

Conmed's quarterly Short-Term Debt increased from Dec. 2025 (MXN13 Mil) to Mar. 2026 (MXN13 Mil) and increased from Mar. 2026 (MXN13 Mil) to Jun. 2026 (MXN3,092 Mil).

Conmed's annual Short-Term Debt increased from Dec. 2023 (MXN12 Mil) to Dec. 2024 (MXN15 Mil) but then declined from Dec. 2024 (MXN15 Mil) to Dec. 2025 (MXN13 Mil).

Conmed Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Conmed Short-Term Debt Related Terms

Conmed Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Conmed's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed Short-Term Debt Chart

Conmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 251.28 1,359.77 12.02 14.91 12.82

Conmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.44 13.69 12.82 12.82 3,091.95
MEX:CNMD
80GF Score
Conmed Corp MEX:CNMD
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of MXN3,092 Mil mean?
Conmed (MEX:CNMD) has a Short-Term Debt of MXN3,092 Mil as of Jun. 2026.
Is Conmed's Short-Term Debt too high?
Conmed's current Short-Term Debt is MXN3,092 Mil. Overall, Conmed has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Conmed's Short-Term Debt compare to TNDM and ATEC?
Conmed's Short-Term Debt of MXN3,092 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Conmed's current Short-Term Debt is MXN3,092 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Conmed (MEX:CNMD) has a current Short-Term Debt of MXN3,092 Mil. The stock's GF Value™ is MXN989.85, compared to a current price of MXN720.00 — trading 27.3% below its estimated fair value. The current Short-Term Debt is MXN3,092 Mil. Conmed's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Conmed (MEX:CNMD), the current Short-Term Debt is MXN3,092 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Conmed (MEX:CNMD) Overvalued in 2026?

Based on GuruFocus' analysis, Conmed stock appears to be undervalued. The current stock price of MXN720.00 is trading 27.3% below its estimated GF Value™ of MXN989.85.

Key valuation signals for MEX:CNMD:

  • Short-Term Debt: MXN3,092 Mil
  • GF Value™: MXN989.85 vs. price of MXN720.00 (27.3% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the MEX:CNMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Conmed Business Description

Other Exchanges CNMD:USA
Address 11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
80GF Score

Get the complete analysis for MEX:CNMD

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN720.00
Price
MXN989.85
GF Value